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Aims Adaptive immunity contributes to the pathogenesis of cardiovascular metabolic disorders (CVMD). The omega-3
polyunsaturated fatty acids (n-3PUFA) are beneficial for cardiovascular health, with potential to improve the dysre-
gulated adaptive immune responses associated with metabolic imbalance. We aimed to explore the mechanisms
through which n-3PUFA may alter T cell motility and tissue distribution to promote a less inflammatory environ-
ment and improve lymphocyte function in CVMD.
....................................................................................................................................................................................................
Methods
and results
Using mass spectrometry lipidomics, cellular, biochemical, and in vivo and ex vivo analyses, we investigated how eicosa-
pentaenoic acid (EPA) and docosahexaenoic acid (DHA), the main n-3PUFA, modify the trafficking patterns of acti-
vated CD4þ T cells. In mice subjected to allogeneic immunization, a 3-week n-3PUFA-enriched diet reduced the num-
ber of effector memory CD4þ T cells found in adipose tissue, and changed the profiles of eicosanoids, octadecanoids,
docosanoids, endocannabinoids, 2-monoacylglycerols, N-acyl ethanolamines, and ceramides, in plasma, lymphoid
organs, and fat tissues. These bioactive lipids exhibited differing chemotactic properties when tested in chemotaxis
assays with activated CD4þ T cells in vitro. Furthermore, CD4þ T cells treated with EPA and DHA showed a signifi-
cant reduction in chemokinesis, as assessed by trans-endothelial migration assays, and, when implanted in recipient
mice, demonstrated less efficient migration to the inflamed peritoneum. Finally, EPA and DHA treatments reduced the
number of polarized CD4þ T cells in vitro, altered the phospholipid composition of membrane microdomains and de-
creased the activity of small Rho GTPases, Rhoa, and Rac1 instrumental in cytoskeletal dynamics.
....................................................................................................................................................................................................
Conclusions Our findings suggest that EPA and DHA affect the motility of CD4þ T cells and modify their ability to reach target
tissues by interfering with the cytoskeletal rearrangements required for cell migration. This can explain, at least in
part, the anti-inflammatory effects of n-3PUFA supporting their potential use in interventions aiming to address adi-
pocyte low-grade inflammation associated with cardiovascular metabolic disease.
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1. Introduction
Chronic low-grade inflammation is a key feature of cardiovascular meta-
bolic disorders (CVMD), a group of diseases where T cell-mediated
adaptive immunity has been considered to play an important role.1–3
T cells infiltrate atherosclerotic plaques and obese adipose tissue, driving
disease progression through pro-inflammatory immune responses
mediated by CD4þ T-helper type 1 (Th1) and CD8þ cytotoxic T lym-
phocytes preponderant over immunomodulatory (Th2) and immu
nosuppressive (T regulatory - Treg) immunity.1,2 Recruitment and activa-
tion of macrophages release of pro-inflammatory cytokines while altered
regulatory mechanisms further perpetuate inflammation.1,4 As we have
recently shown, fat overload leads to a biased differentiation of a pro-
inflammatory effector memory-like population of CD4þ T cells, both in
humans and mice, contributing to the low-grade inflammation observed
in obesity.5
The omega-3 (n-3) polyunsaturated fatty acids (PUFA) eicosapentae-
noic (EPA) and docosahexaenoic (DHA) acids, found in fish oils, have
been explored as means of preventing cardiovascular disease and
improving cardiometabolic risk factors.6–8 Although the efficiency of
n-3PUFA is debated, recent clinical studies have shown that EPA supple-
mentation can reduce the risk of ischemic events and increase the stabil-
ity of the atherosclerotic plaque, with EPA plaque levels inversely related
to their T cell content.9–12 Furthermore, n-3PUFA suppress antigen
presentation, activation, and proliferation, and lower the expression of
cytokines by T cells.13–15 While the immunomodulatory properties of
n-3PUFA are appreciated, the underpinning molecular mechanisms are
not fully understood. Recent findings indicate that EPA induces the differ-
entiation of regulatory T cells through the up-regulation of peroxisome
proliferator-activated receptor c,16 while DHA alters the composition
and molecular organization of membrane microdomains, with conse-
quent changes in the activity of signalling proteins linked to actin remod-
elling, overall, leading to reduced CD4þ T cell activation.17–19
Further to altering membrane composition, n-3PUFA can dispense ac-
tivities via their metabolism to bioactive lipid mediators of inflammation
and immunity, many of which are key players in the cardiovascular sys-
tem.17,20,21 Membrane esterified omega-6 (n-6) PUFA, such as linoleic
acid (LA) and arachidonic acid (AA), compete with n-3PUFA for the
same enzymes and yield an array of pro- and anti-inflammatory eicosa-
noids, octadecanoids, and docosanoids, including pro-resolving media-
tors (e.g. resolvins, protectins, maresins).20–22 Endocannabinoids
and other N-acyl ethanolamines (NAE) are PUFA derivatives with strong
involvement in the cardiovascular system, inflammation, and immu-
nity.21,23 n-3PUFA can also influence the production of ceramides,
potent lipid mediators of cell differentiation, and apoptosis, also involved
in insulin metabolism and lipotoxicity underpinning cardiovascular dis-
ease.24–26
Systemically and locally produced lipid mediators interact with T cells
through cell surface receptors affecting activation, differentiation, prolif-
eration, cytokine production, motility, and homing events.21 Examples
include the pro-inflammatory and immunosuppressive prostaglandin E2
(PGE2) that stimulates differentiation of lymphocytes influencing the de-
velopment and balance of Th1, Th2, and Th17 subsets in a
concentration-dependent manner,21,27 the endocannabinoid anandamide
(AEA) that inhibits T cell proliferation and was shown to be immunosup-
pressive,28 and ceramide-1-phosphate (C1P) that promotes cell migra-
tion although its effect on T cell function remains to be explored.29,30
Modifying the trafficking patterns of activated T cells can promote a
less inflammatory environment and improve cardiovascular health;
therefore, in-depth understanding of the mechanisms underpinning the
n-3PUFA effects on T cell-mediated immune responses is of importance.
As well as elucidating the currently debated role of EPA and DHA on
cardiovascular health, such detailed insight can support improved inter-
ventions and reveal the identity of lipid species with immune-modulatory
activities that could instigate the design of novel therapeutics. In this
study, we used mice subjected to allogeneic immunization after a diet
supplemented with n-3PUFA. Altered distribution of activated CD4þ
T cells in fat tissues revealed the impact of n-3PUFA on the ratio of effec-
tor to central memory CD4þ T cells, while mediator lipidomics revealed
bioactive lipids with differing chemotactic properties, formed systemi-
cally and in the target tissues. Treating CD4þ T cells with EPA and DHA
ex vivo showed that n-3PUFA could modify membrane microdomains
and regulate the signalling events involved in the cytoskeletal dynamics
influencing the T cell migratory capabilities.
2. Materials and methods
2.1 Animal study
All in vivo experiments were conducted under the UK Home Office regu-
lation and conformed to the guidelines from Directive 2010/63/EU of
the European Parliament on the protection of animals used for scientific
purposes. All animals were euthanized via exposure to rising concentra-
tion of CO2, according to humane schedule 1 procedures. To study the
effect of n-3PUFA supplementation on T cell distribution and composi-
tion, wild-type (WT) C57BL/6 female mice were randomly allocated to
groups (n= 5 animals per group) fed either chow diet (CD) or CD sup-
plemented with 10% salmon oil (CDþx3) for 3 weeks (Supplementary
material online, Table S1) [Special Diet Service (SDS)], as previously
reported.31 Immunization was performed during the third week of sup-
plementation (Section 2.2).
2.2 T cell activation
In vitro: murine CD4þ T cells were isolated with commercially available
isolation kits (negative selection; EasySep, Invitrogen) according to the
manufacturer’s instructions from pooled lymph nodes (inguinal, mesen-
teric, axillary, brachial, superficial and deep cervical, lumbar, and sacral)
and spleen of C57BL/6 female mice and activated with plate bound anti-
CD3 (1 mg/mL, eBioscience), anti-CD28 (5 mg/mL, eBioscience), and IL-
2 (10 ng/mL, Roche) for 3–4 days; they were then treated overnight with
EPA or DHA (free fatty acids dissolved in ethanol) (20lM; Cambridge
Bioscience) as previously reported;32 this was followed by a treatment
with CXCL10 (300 ng/mL) for 1 h with or without methyl-b-cyclodex-
trin (MbCD; 5 mM; Sigma). Alternatively, on the third day of activation,
T cells were treated overnight with the indicated lipid mediators (free
forms dissolved in ethanol) (10 nM; Cambridge Bioscience).
In vivo: in WT C57BL/6 female mice fed CD or CDþx3 for 3 weeks,
memory CD4þ T cells were generated by i.p. immunization with WT
Balb/c and CD-1 male splenocytes (1.5 106) for 7 days. T cells were
then isolated from mesenteric (draining) lymph nodes (mLNs), spleen,
cardiac fat, perigonadal fat, and subcutaneous fat and used for flow
cytometry.
2.3 Peritoneal recruitment
In vitro activated CD4þ T cells were pre-treated with EPA or DHA
(20lM), labelled with 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacri-
din2-one) (DDAO) (Invitrogen) and intravenously injected in recipient
syngeneic female C57BL/6 mice (5 106 cells/mouse) that had 3 h prior
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received an intraperitoneal injection with CXCL10 (1200 ng/mouse)
(n= 4–6 animals); 24 h later, peritoneal lavage and spleen were collected
and analysed by FACS for presence of DDAO-labelled T cells.
2.4 Membrane and intracellular FACS
staining
Spleen samples were lysed of their RBCs before staining. Dead cells
were excluded from analysis by staining with fixable Aqua Dead Cell
Stain (Invitrogen). Isolated lymphocytes were stained for surface
markers: CD4, CD44, CD62L, LFA1, CXCR3, and CD25 (Figure 1A–F,
n= 3–5 animals per group; Figure 4B, n= 4–6, Figure 4C, n= 3 indepen-
dent experiments; Supplementary material online, Figure S3A–C, n= 3 in-
dependent experiments) with fluorescently conjugated primary
antibodies (1:200, eBioscience/BioLegend) at 4C for 30 min in FACS
buffer [phosphate buffered saline (PBS)þ 2% FCSþ 0.1% sodium azide]
and fixed at 4C for 30 min with 1% PFA in FACS buffer. For intracellular
staining, isolated lymphocytes were incubated in permeabilization/fixa-
tion buffer (eBioscience) at 4C for 1 h. Samples were washed in perme-
abilization buffer and stained for Foxp3 (1:200, eBioscience/BioLegend)
with fluorescently conjugated primary antibodies at 4C for 30 min in
permeabilization buffer. In Supplementary material online, Figure S3D,
proliferation of CD4þ T cells was assessed by dilution of CFSE (3.3lM,
Invitrogen) (n= 9 independent experiments). All samples were then
assessed by flow cytometry using an LSRFortessa (BD Biosciences) and
FlowJo version 10 software. Dot plots were concatenated to show the
independent biological replicates used in each experiment.
2.5 Isolation of lymphocytes from fat tissue
Cardiac, perigonadal, and subcutaneous fat were harvested from mice
fed CD or CDþx3 for 3 weeks, cut in small pieces and suspended in a
solution of PBSþ 5% BSA containing Collagenase Type II (Sigma) and
calcium chloride. Samples were incubated for 20 min at 37C in agitation
to allow tissue digestion; they were then filtered through a 70lm cell
strainer and the collected cell suspension was washed and stained for
FACS analysis. Any blood contamination was removed by lysis of red
cells with RBC lysis buffer. The weight of the fat tissues harvested from
all animals used is shown in Supplementary material online, Table S2.
2.6 Chemotaxis
Chemotaxis assays were performed in 5lm transwell inlays (Corning).
In vitro activated lymphocytes were suspended in migration medium
(RPMI 2% FCS) and seeded in the upper transwell chamber (3 105
cells/transwell). Chemokine CXCL10 (300 ng/mL) (PeproTech) was
added to the lower chamber, or alternatively the indicated lipid media-
tors at a concentration of 10 nM or other as indicated. Migrated T cells
were counted with a haemocytometer at 2, 4, and 6 h after seeding, and
then the percent of migrated cells was calculated (n= 7 animals in Figure
3A and B; n= 3 animals in Figure 4D). In some assays, microvascular endo-
thelial cells (isolated from the lungs of C57BL/6 mice) were seeded
(3 104 cells/well) on 3lm transwell inlays.33 On the following day,
T cells (3 105 cells/well) suspended in migration medium were added
to the top chamber of the transwell and incubated at 37C with 5% CO2
to allow migration through the endothelial monolayers. Migrated T cells
were counted with a haemocytometer at 6 and 24 h after seeding, then
the percent of migrated cells was calculated (Figure 4A, n= 3 independent
experiments).
2.7 Cytotoxicity assay
Cytotoxicity was assessed by the MTT assay performed using the
CellTiter 96 AQueous One Solution Cell Proliferation colorimetric as-
say (Promega), according to the manufacturer’s instructions. Briefly:
in vitro activated T cells (5 104 cells) were treated overnight with in-
creasing fatty acid concentrations (1–100lM); they were then seeded
into each well of a 96-well plate and CellTiter 96 AQueous One
Solution reagent was added (20lL per well). After 1 h incubation, absor-
bance (490 nm) was measured in a microplate reader (n= 3 independent
experiments; Supplementary material online, Figure S3F).
2.8 Western blot
Protein lysates were prepared from CD4þ T lymphocytes isolated from
pooled lymph nodes and activated as described above. Samples were
lysed in Nonidet P-40 lysis buffer (50 mM HEPES pH 8.0, 350 mM NaCl,
1% Nonidet P-40, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 20 mM
glycerol-2-phosphate, 1 mM PMSF, 1 mM DTT, 10 mg/mL aprotinin,
10 mg/mL leupeptin, and a protease inhibitor mixture; Roche).
Equivalent amounts of protein as determined by standard Bradford assay
(Bio-Rad) were separated by SDS/PAGE and transferred to a Nylon
membrane (GE Healthcare). Membranes were blocked for 1 h at room
temperature in 5% Milk/TBS-T, incubated overnight at 4C with primary
antibodies (1:1000), and subsequently with horseradish peroxidase-con-
jugated secondary antibody (Amersham Bioscience) (1:5000).
Antibodies against Rhoa and Rac1 were purchased from Cytoskeleton,
Inc. p-PAK1/2, p-MLC2, and b-actin were purchased from Cell Signalling.
Pull-down of the active form of Rhoa and Rac1 were performed, respec-
tively, with Rhotekin-RBD protein GST beads and PAK-GST protein
beads according to the manufacturer’s instruction.
2.9 Immunofluorescence
CD4þ T cells isolated from lymph nodes and spleen of C57BL/6 female
mice were activated in vitro for 3 days; on the third day of activation, cells
were treated overnight with EPA, DHA, or oleic acid (20lM) (n= 3 in-
dependent experiments). The day after, cells were treated with
CXCL10 300 ng/mL for 1 h and, where indicated, with MbCD (5 mM;
Sigma) (n= 3 independent experiments); then cells were suspended in
PBS and allowed to attach for 1 h in incubator at 37C onto coverslips
pre-treated with Cell-tack (Corning). Cells were then washed, fixed in
3.7% PFA for 20 min, permeabilized with PBS containing 0.2% Triton
X-100, blocked with PBS containing 1% BSA and 0.02% Triton X-100 for
30 min and incubated with 6.6lM Phalloidin (F-actin staining, Thermo
Fisher Scientific) and 0.3lM DnaseI (G-actin staining, Thermo Fisher
Scientific) for 30 min. Anti-Rhoa (Cytoskeleton, Inc.) mouse antibody
was incubated for 2 h (1:100) and revealed with anti-mouse Alexa fluor
569 for 45 min. Nuclei were stained with DAPI (300 nM; Thermo Fisher
Scientific). Finally, coverslips were mounted onto slides using a DAKO
mounting medium. Images were acquired using a confocal microscopy
and analysed using ZEN software; in Supplementary material online,
Figure S5, images were acquired using a fluorescence microscope (Leica
AF60000) and LAS X Software.
2.10 Mediator lipidomics
Extraction and analysis of prostanoids and hydroxy fatty acids was per-
formed as described previously.34,35 Briefly, plasma (100–200lL) or
solid tissue (20–60 mg) samples (n= 6 animals per group) were homoge-
nized in ice-cold methanol (15% v/v), spiked with a mixture of deuter-
ated internal standards (40 ng each of 12-HETE-d8, 8,9-DHET-d11,
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Figure 1 n-3PUFA supplementation alters the distribution of T cell subsets in fat tissue and lymphoid organs. (A–F) Cell surface staining of CD4 (A),
CD44 (B), CD62L (C and D), LFA1 (E), CD25, and Foxp3 (F) in in vivo primed CD4þ T cells isolated from the indicated tissues of female C57BL/6 WT mice
fed a chow (CD) or chow with 10% salmon oil (CDþx3) diet for 3 weeks. In (A), the absolute number of CD4þ T cells in cardiac, perigonadal, and subcuta-
neous fat has been normalized to the amount of tissue (mg) harvested. Multiple t-tests followed by Holm Sidak post-hoc correction (n= 3–5 animals per
group). Values denote mean ± SEM. *P< 0.05; **P< 0.01; and ***P< 0.001.
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Figure 2 Effect of n-3PUFA supplementation on eicosanoids, docosanoids, and octadecanoids (A), endocannabinoids and N-acyl ethanolamines (B) and
ceramides (C), sphingoid bases and phosphorylated ceramides (D) found in fat tissue, lymphoid organs, and plasma. Tissue was obtained from female C57BL/
6 WT mice fed a chow (CD) or chow with 10% salmon oil (CDþx3) diet. Data are expressed as ng/mg protein in solid tissues and ng/mL in plasma.
*P< 0.05, **P< 0.01, ***P< 0.001, and ****P< 0.0001 based on multiple t-tests followed by Holm Sidak post-hoc correction (n= 6 animals per group).
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8,9-EET-d11, and PGB2-d4) and incubated in the dark. Solid phase ex-
traction (SPE) (C18 cartridges; Phenomenex, Macclesfield, UK) was used
to clean-up the supernatants, which were then acidified and added to
the pre-conditioned SPE cartridges. Lipids were eluted with methyl for-
mate and analysed by ultrahigh performance chromatography (UPLC;
Acquity, Waters, USA) coupled to a triple quadrupole mass spectrome-
ter with an electrospray ionization source (Xevo TQS, Waters) (UPLC/
ESI-MS/MS) in the negative ionization mode on a C18 column (Acquity
UPLC BEH C18; 50 2.1 mm, 1.7lm; Waters, UK). Instrument and
data analysis were carried out by TargetLynx software (Waters, UK).
Data reported were normalized with the use of internal standards and
quantified using internal calibration curves constructed with commer-
cially available standards.
Extraction and analysis of endocannabinoids, NAE, 2-monoacylglycer-
ols (MG), ceramides, phosphorylated ceramides, phosphorylated bases,
and free sphingoid bases were performed as described.34,36 Briefly,
plasma (100–200lL) or solid tissue (20–60 mg) samples were homoge-
nized in ice-cold chloroform/methanol (2:1, v/v), spiked with a mixture
of internal standards [20 ng of AEA-d8 and 40 ng of 2-AG-d8, 20 ng of
CERN(18)S(18)-d3, 20 ng of CERN(16)DS(18)-d9 and CERA(16)S(18)-
d9 and 50 pmol of Cer/Sph Mixture I; Cayman Chemicals, Ann Arbour,
MI, USA; Avanti Polar Lipids, USA], and incubated in the dark. Analytes
were recovered in the organic layer and analysed by UPLC/ESI-MS/MS
using a C18 column (Acquity UPLC BEH C18; 50 2.1 mm, 1.7lm;
Waters, UK) for endocannabinoids and NAE, and a C8 column (Acquity
UPLC BEH C8; 100 2.1 mm; 1.7lm; Waters, UK) for ceramides; all in
the positive ionization mode. In the case of solid tissues the organic layer
was cleaned up by SPE (Strata SI-1-Silica; Phenomenex, Macclesfield, UK)
before their analysis by UPLC/ESI-MS/MS. Instrument and data analysis
were carried out by TargetLynx software (Waters, UK). Data reported
were normalized using internal standards; endocannabinoids, 2-MG, and
NAE were quantified using internal calibration curves constructed with
commercially available standards; relative quantification of ceramides
was performed using internal standards.
Protein content was performed on the protein pellets retained during
the lipid extractions using protein assay kit (Bio-Rad, Hemel Hempstead,
UK), as described.34
2.11 Isolation and lipid analysis of
detergent-resistant membrane
microdomains
The insolubility of membrane microdomains in non-ionic detergents,
such as Brij-58, at 4C is the most common method used to isolate de-
tergent-resistant membranes (DRM); low density DRM are a crude rep-
resentation of ‘lipid raft microdomains’. Here, DRM were isolated from
murine T cells (Figure 6A, n= 4 independent experiments; Figure 6B and
C, n= 5 independent experiments) as described before.37 Briefly, T cells
were lysed with a lysis buffer (100 mM NaCl, 2 mM EDTA, 4.1 mM
AEBSF, 0.2 mM Na3VO4, 50lM NaF, 25 mM HEPES, 3.2lM aprotinin,
88lM leupeptin, 160lM bestain, 60lM pepstain A, and 56lM E-64, pH
6.9) containing 1% Brij-58. Cell lysates were passed through a 27G nee-
dle once and incubated on ice in the dark. Cell lysates were mixed with
330lL of 85% sucrose prepared in lysis buffer. Then, 1 mL of 35% su-
crose and 300lL of 5% sucrose were subsequently overlaid. Samples
were ultracentrifuged at 200 000 g (Beckman Coulter Optima Max-E ul-
tracentrifuge, TLS 55 rotor) overnight at 4C. Then, 10 aliquots of
200lL were collected from the top to the bottom sequentially, to gen-
erate 10 fractions (Fr. 1–5% sucrose; Fr. 2–9.2% sucrose; Fr. 3–13.3%
sucrose, Fr. 4–17.5% sucrose; Fr. 5–21.7% sucrose; Fr. 6–25.8% sucrose;
Fr. 7–30.0% sucrose; Fr. 8–34.2% sucrose; Fr. 9–38.3% sucrose; Fr. 10–
42.5% sucrose).
Figure 3 Lipid mediators affect CD4þ T cell migration, in vitro.
Chemotaxis assay of in vitro activated CD4þ T cells isolated from
pooled lymph nodes and spleens of female C57BL/6 WT mice in re-
sponse to the cytokine CXCL10 (300 ng/mL), the eicosanoids PGE2
and 12-HEPE, the octadecanoid 9-HOTrE, the docosanoid 19, 20-
DiHDPA, the endocannabinoid AEA, and C1P N(16)S(18)C1P
(10 nM), the combination of the cytokine and lipid treatment, or media
only (indicated by the red line; CTRL). In (A), lipid mediators are tested
for their ability to affect CD4þ T cells migratory capabilities; conversely,
in (B) their capacity to counteract or synergize with CXCL10 is mea-
sured. The number of migrated cells is reported as a percentage nor-
malized to media only control. Two-tailed Student’s t-test (n= 7
independent experiments). The values denote mean ± SEM. *P< 0.05;
**P< 0.01 vs. CTRL (red line); and #P< 0.05 vs. CXCL10 (B).
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Figure 4 EPA and DHA reduce the migratory capacity of CD4þ T cells, both in vitro and in vivo. (A) Trans-endothelial migration (6 h and 24 h time points)
of in vitro activated CD4þ T cells in the presence of EPA (20lM) or DHA (20lM). (B) Relative enrichment of i.v.-injected activated CD4þ T cells pre-treated
with EPA (20lM) or DHA (20lM) and subsequently labelled with 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin2-one) (DDAO) cell fluorescent dye in
the peritoneal lavage of syngeneic recipient C57BL/6 mice i.p.-injected with CXCL10 (1200 ng/mouse). (C) Cell surface staining of the CXCL10 receptor
CXCR3 in CD4þDDAOþ T cells isolated from the peritoneal lavage of mice in (B). UT denotes untreated control cells. (D) Chemotaxis assay of in vitro acti-
vated CD4þ T cells isolated from pooled lymph nodes and spleens of female C57BL/6 WT mice in response to the chemokine CXCL10 (300 ng/mL) or the
eicosanoid 18-HEPE (10 nM); also EPA (5 and 20lM), Oleic acid (5 and 20lM) and Palmitic acid (5 and 20lM) in combination with CXCL10, or media only
(indicated by the red line; CTRL). Two-tailed Student’s t-test [(A) n= 3 independent experiments; (B) n= 4–6 animals per group; (C) n= 3 animals per group;
(D) n= 3 independent experiments]. The values denote mean ± SEM. *P< 0.05; **P< 0.01; ***P< 0.001; and ##P< 0.01 vs. CXCL10 (D).
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Figure 5 EPA and DHA alter the polarization of CD4þ T cells and down-regulate the expression of small Rho GTPases. (A) Double immunofluorescence
staining for F-actin (green) and G-actin (red) in in vitro activated CD4þ T cells, overnight treated with EPA (20lM) and DHA (20lM) and stimulated with
the cytokine CXCL10 (300 ng/mL) for 1 h prior to fixation. Quantification of the % of polarized cells is provided upon counting polarized cells (cells showing
one or more pseudopods) in at least 10 images per condition. The ratio F-actin/G-actin is calculated using the intensity of the staining as provided by the soft-
ware used for the acquisition and analysis of the images (ZEN), each dot represents a single cell analysed (an average of 30 cells were analysed in each exper-
iment). Images were acquired using a confocal microscope. Scale bar = 10mm. (B and C) Western blot analysis of Rhoa (total and activated), phospho-
MLC2, Rac1 (total and activated), phospho-PAK1/2, and b-actin in in vitro activated CD4þ T cells overnight treated with EPA (20lM) or DHA (20lM) and
stimulated with CXCL10 (300 ng/mL) for 1 h prior to lysis; UT denotes untreated control cells. (D) Double immunofluorescence staining for F-actin (green)
and Rhoa (red) in in vitro activated CD4þ T cells, overnight treated with EPA (20lM) and DHA (20lM) and stimulated with CXCL10 (300 ng/mL) for 1 h
prior to fixation. Scale bar = 10mm. Two-tailed Student’s t-test (n= 3 independent experiments). The values denote mean ± SEM. *P< 0.05 and
****P< 0.0001.
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..Extraction and analysis of membrane lipids were performed as de-
scribed before.38 Briefly: sucrose gradient fractions (200 lL) were
mixed with ice-cold chloroform/methanol (2:1, v/v), spiked with a
mixture of internal standards [200 lg each of palmitic acid-d31, 15:0
cholesteryl-d7 ester, 16:0-d31-18:1 phosphatidylcholine, 16:0-d31-
18:1 phosphatidylethanolamine, 17:0-17:1-17:0-d5 triacylglycerol;
26:0-d4 lysophosphatidylcholine, 16:0-d31 sphingomyelin (SM), 18:1-
d5 diacylglycerol and 18:1-d7 lysophosphatidylethanolamine, and
400 lg cholesterol-d7] (Avanti Polar Lipids) and incubated on ice in
the dark. The organic layer containing the lipids was recovered by cen-
trifugation after the addition of water, evaporated to dryness and
reconstituted in chloroform/2-propanol (1:1, v/v). Lipid analysis was
carried out by ultra-high-performance supercritical fluid chromatog-
raphy (UHPSFC; Acquity UPC2, Waters) coupled to a quadrupole-
time-of-flight mass spectrometer (Synapt G2 High Definition Q-TOF,
Waters, Milford, MA, USA) (UHPSFC/ESI-QTOF-MSE), in the positive
and negative ionization mode, using an Acquity UPC2 Torus 2-PIC col-
umn (Waters). Instrument and data analysis were carried out by
TargetLynx software (Waters, UK). Data processing was carried out
using Progenesis QI (Waters), which aided TIC-based chromatogram
alignment and peak picking. Lipid identification was performed and
confirmed through fragmentation patterns, using the LIPID MAPS
database and in-house information. Relative quantification was esti-
mated using deuterated internal standards.
2.12 Statistical analysis
Data are expressed as mean± standard error of the mean (SEM), using
n= 3–6 animals per group (Figures 1, 2, and 4) and n= 3–7 independent
experiments per group (Figures 3–7), unless otherwise stated in the
methods section. Data distribution was assessed for normality using the
Shapiro–Wilk and Kolmogorov–Smirnov normality tests. For the cell
and animal studies, the data were parametric. The lipidomics data were
mainly parametric although the distribution of some lipid species in
some of the tissues examined was not parametric. We therefore ana-
lysed the data with parametric and non-parametric tests and performed
sensitivity tests in the raw and log transformed data; in all cases we came
Figure 6 Distribution of sphingomyelin (SM), phosphatidylcholine (PC), and phosphatidylethanolamine (PE) species in untreated (A), DHA-treated (B), or
EPA-treated (C) CD4þ T cell membrane microdomains and the distribution of monounsaturated (MUFA) and polyunsaturated fatty acids (PUFA) (D). Cells
were lysed with detergent (Brij-58; 1%) and membranes fractionated by ultracentrifugation using a sucrose gradient, with density increasing from fraction 1
(Fr. 1–5% sucrose) to fraction 10 (Fr. 10–42.5% sucrose). The relative abundance of lipid species in each fraction was estimated by supercritical fluid chroma-
tography coupled to time of flight mass spectrometry. The composition of membrane microdomains separated by each sucrose fraction is shown as
increased degree of unsaturation of the relevant lipid species. Data are expressed as % of total. *P< 0.05 based on one-way ANOVA followed by Tukey
post-hoc test (n= 4–5 independent experiments).
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up with similar results, therefore the initial analysis using parametric tests
was applied. The tests used were two-tailed Student’s t-tests and multi-
ple t-tests with Holm Sidak post-hoc test for multiple comparisons or
one-way ANOVA with Tukey post-hoc test. All analyses were performed
using GraphPad Prism version 7.00. In all cases, a P-value of <0.05 was
considered to be significant.
3. Results
3.1 Tissue distribution of CD4þ T cells post
n-3PUFA supplementation
The effect of n-3PUFA supplementation on the distribution of the main
CD4þ T cell subsets in adipose tissues and lymphoid organs was
Figure 7 Disruption of lipid rafts recapitulates the effect of EPA and DHA on the cytoskeletal dynamics of CD4þ T cells. (A) Double immunofluorescence
staining for F-actin (green) and G-actin (red) in in vitro activated CD4þ T cells treated with methyl-b-cyclodextrin (MbCD) (5 mM) for 1 h in the presence of
the cytokine CXCL10 (300 ng/mL). Quantification of the % of polarized cells is provided upon counting polarized cells (cells showing one or more pseudo-
pods) in at least 10 images per condition. The ratio F-actin/G-actin is calculated using the intensity of the staining as provided by the software used for the ac-
quisition and analysis of the images (ZEN), each dot represents a single cell analysed (an average of 30 cells were analysed in each experiment). Images were
acquired using a confocal microscope. Scale bar = 10mm. (B) Double immunofluorescence staining for F-actin (green) and Rhoa (red) in in vitro activated
CD4þ T cells, treated with MbCD (5 mM) in the presence of CXCL10 (300 ng/mL) for 1 h prior to fixation. Scale bar = 10mm. (C) Western blot analysis of
Rhoa, Rac1, phospho-PAK1/2, and b-actin in in vitro activated CD4þ T cells treated with MbCD (5 mM) for 1 h in the presence of CXCL10 (300 ng/mL) and
untreated control (UT). Two-tailed Student’s t-test (n= 3 independent experiments). The values denote mean ± SEM. *P< 0.05 and ***P< 0.001.
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examined. No major changes in body parameters, including weight, were
observed after 3 weeks of CDþx3 diet compared to CD, which was in
line with our previous data.6 Lymphoid organs (spleen and mLNs) and
adipose tissue from different areas of the body, namely the heart (cardiac
fat), lower peritoneum (perigonadal fat), and skin (subcutaneous fat)
were harvested 7 days after immunization and the number and subtypes
of CD4þ T cells were assessed by FACS. We found that, in the n-3PUFA
supplemented animals (CDþx3 group), the overall number of CD4þ
T cells (as normalized to fat tissue weight; Supplementary material on-
line, Table S2), was not significantly different as compared to untreated
controls (CD group); similarly, no difference was observed in the num-
ber of CD4þ T cells found in the lymphoid organs (Figures 1A and
Supplementary material online, Figure S1A).
Dietary supplementation with n-3PUFA also led to a reduction in the
relative abundance of activated memory CD44þ T cells (assessed as %
of total CD4þ T cells), both in fat (with the only exception of perigona-
dal fat) and lymphoid tissues (Figure 1B and Supplementary material on-
line, Figure S1B). Importantly, the n-3PUFA diet altered the balance
between central and effector memory CD4þ T cell populations in the
fat tissues examined, leading to a statistically significant reduction in the
CD44hiCD62Llo (cardiac fat P< 0.001, subcutaneous fat P< 0.001, mLNs
P< 0.01) and CD44þLFA1þ (cardiac fat P< 0.05, subcutaneous fat
P< 0.05) effector memory CD4þ T cell population, while it increased
the CD44hiCD62Lhi central memory CD4þ T cell subset (cardiac fat
P< 0.01, perigonadal fat P< 0.05, subcutaneous fat P< 0.05) (Figure 1C–E
and Supplementary material online, Figure S1C and D, respectively).
Furthermore, analysis of the regulatory CD25þFoxp3þ (Treg) CD4þ
T cells, showed a trend towards an increase in the Treg population found
in the fat tissues of animals fed the n-3PUFA-supplemented diet, as com-
pared to animals fed standard CD (Figure 1F and Supplementary material
online, Figure S1E).
3.2 Tissue profiling of lipid mediators post
n-3PUFA supplementation
As CD4þ T cell function may be affected by chemotactic lipid mediators,
we employed lipidomics performed by UPLC/ESI-MS/MS34–36,39 to ana-
lyse various eicosanoids, docosanoids, octadecanoids, endocannabinoids,
NAE, 2-MG, ceramides, and sphingoid bases, in plasma, spleen, lymphoid,
and adipose tissues of the animals fed CD and CDþx3 diets (Figure 2).
Although mLNs and spleen had the largest number and diversity of
cyclooxygenase-derived (COX) prostanoids and lipoxygenase (LOX-)
and cytochrome P450 (CYP-) hydroxy- and epoxy-fatty acids detected
(all members of the eicosanoid, octadecanoid, and docosanoid classes),
cardiac, perigonadal, and subcutaneous fat and plasma appeared to pro-
duce the most abundant species at higher concentrations (Figure 2A).
The n-3PUFA diet reduced levels of AA-derived prostanoids and in-
creased EPA- and dihomo-c-linolenic acid (DGLA)-derived species in all
tissues examined. Specifically: statistical significant decrease of PGF2a in
cardiac fat (P< 0.0001) and spleen (P< 0.01), PGE2 in perigonadal fat
(P< 0.05), and prostacyclin (measured as 6-keto PGF1a) in cardiac fat
(P< 0.01) were observed, while levels of 8-iso-PGF2a (P< 0.01), PGE3
(P< 0.001), and TXB3 (P< 0.01) in spleen and PGD3 (P< 0.01) in mLNs
were significantly increased. Furthermore, the n-3PUFA supplementa-
tion reduced most AA-, a-linolenic acid- and DGLA-derived mediators
formed via the LOX and CYP pathways, with concomitant increases in
DHA-, EPA- and LA-derived species. The following mediators were sig-
nificantly increased: 9-HOTrE in cardiac fat (P< 0.01) and mLNs
(P< 0.001); 7-HDHA (P< 0.01) in mLNs; 11-HDHA (P< 0.001) in
mLNs; 5-HEPE in mLNs (P< 0.001), spleen (P< 0.01), and plasma
(P< 0.001); 20-HDHA in mLNs (P< 0.01) and plasma (P< 0.01); 11-
HEPE in mLNs (P< 0.001) and spleen (P< 0.001); 18-HEPE in mLNs
(P< 0.0001), spleen (P< 0.0001), and plasma (P< 0.01); and 19,20-
DiHDPA in mLNs (P< 0.0001) and spleen (P< 0.001). 15-HETE was sig-
nificantly decreased in spleen (P< 0.001).
Due to limited sample availability, endocannabinoids, NAE, 2-MG, and
ceramides were only analysed in perigonadal and subcutaneous fat,
spleen, and plasma (Figure 2B–D). Although plasma showed the highest
concentrations of 2-MG species, 2-AG was found mostly in spleen.
Interestingly, the fish oil diet significantly reduced production of AEA
(P< 0.001) in perigonadal fat, while the n-3PUFA-derived species DPEA
(P< 0.001) and 2-DHG (P< 0.0001) were significantly increased in
spleen (Figure 2B).
CER[NS] and CER[NDS] were the main ceramide classes detected in
all tissues examined; CER[NS] species containing fatty acyl chains of
C14–C18 were found mainly in fat tissues, whereas CER[NS] with lon-
ger acyl chains, i.e. C26–C28, were mostly present in plasma. The highest
number of CER[NDS] ceramides was found in spleen. The less abundant
CER[NP] ceramides were present in adipose tissue and spleen, whereas
CER[ADS] and CER[AP] were found only in fat tissues (Figure 2C and D).
Overall, the n-3PUFA diet, appeared to reduce the number of ceram-
ides, with most significant changes observed in plasma and subcutaneous
fat. In detail: CERN(22)S(18) (P< 0.001), N(22)DS(18) (P< 0.0001),
N(24)P(18) (P< 0.01), N(16)S(18)C1P (P< 0.05), and N(16)DS(18)C1P
(P< 0.01) were reduced in plasma; N(23)DS(18) (P< 0.01), N(26)P(18)
(P< 0.01), and C18S (P< 0.01) were lower in subcutaneous fat; and
N(18)S(18) (P< 0.001) was reduced in spleen. Additionally, a significant
reduction was observed in ceramides with C22 fatty acyl chain (P< 0.01)
in plasma and a significant increase in ceramides with C16 fatty acyl chain
(P< 0.01) in subcutaneous fat, in the n-3PUFA fed group compared to
mice fed on CD (Supplementary material online, Figure S2).
3.3 n-3PUFA and related mediators
directly affect T cell motility and trafficking
The observed altered tissue distribution of CD4þ T cells can be caused
by EPA and/or DHA-induced changes in the production of chemotactic
lipid mediators, both systemically and in the target fat tissues. We there-
fore examined the activity of selected lipid species, namely: the eicosa-
noids PGE2, 12-HEPE and 18-HEPE, the octadecanoid 9-HOTrE, the
docosanoid 19, 20-DiHDPA, the endocannabinoid AEA, and the C1P
N(16)S(18)C1P, and assessed their ability to affect the motility of CD4þ
T cells in ex vivo assays. The bioactive lipids selected represent the classes
of mediators that were found mostly affected by the fish oil diet; their ac-
tivity was assessed at a single concentration (10 nM) that corresponds to
the lower level these mediators were found in the tissues analysed
(Figures 2, 3, and 4D).
Lipid mediators can act as chemoattractants but can also affect the mi-
gratory response of T cells to chemokines;30,40–43 we therefore assessed
both potential modalities of action. When tested for their chemotactic
activity, 19,20-DiHDPA, AEA, and N(16)S(18)C1P appeared to signifi-
cantly increase the migratory response of activated CD4þ T cells (Figures
3A and 4D). Conversely, when tested for their ability to interfere with
the migratory response to the control chemokine CXCL10, CD4þ
T cells pre-treated with 9-HOTrE and PGE2 showed reduced ability to
migrate, compared to CXCL10 alone (Figure 3B).
EPA and DHA were also assessed for their direct impact on the ability
of CD4þ T cells to migrate across an endothelial monolayer. Activated
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CD4þ T cells were treated with EPA and DHA (20lM; 16 h) and
allowed to interact with interferon-c-primed endothelial monolayer.
Both EPA and DHA reduced the trans-endothelial migration of CD4þ
T cells, at 6 h and 24 h after seeding, compared to vehicle control (Figure
4A). This effect was weaker at 24 h showing that the n-3PUFA-induced
inhibition is reversible. Furthermore, both EPA and DHA pre-treated
cells showed impaired traffic to the inflamed peritoneum, in vivo (Figure
4B). Moreover, the n-3PUFA treatment reduced the proportion of
CXCR3þ (CXCL10 receptor) in the population of fluorescently labelled
CD4þ T cells that had reached the peritoneum (Figure 4C), while no dif-
ference was observed in the CD44highCCR7low or CD44highCD62Llow
CD4þ T cells (Supplementary material online, Figure S3A). The inhibitory
effect of n-3PUFA to the chemotactic response to CXCL10 was specific
as no effects were observed with the monounsaturated fatty acid oleic
acid or the saturated fatty acid palmitic acid (Figure 4D).
Finally, we assessed whether EPA and DHA could induce the differen-
tiation of CD4þ T cells to a central memory subset which would explain
the reduced migration through an activated endothelium as well as the
reduced trafficking to the CXCL10-enriched peritoneum. However, we
did not observe any significant effects (Supplementary material online,
Figure S3B and C). Furthermore, treatment with EPA and/or DHA
(20lM, 16 h) (Supplementary material online, Figure S3D and E), or with
a 1–100lM concentration range of EPA, or oleic acid or palmitic acid
(Supplementary material online, Figure S3F) did not alter proliferation or
survival of CD4þ T cells as compared to vehicle treatment.
3.4 EPA and DHA affect cell polarization
and cytoskeleton dynamics
The impact of EPA and DHA on cytoskeletal dynamics, a process under-
pinning all migratory events, was explored using CD4þ T cells treated
with EPA, DHA (20lM) in vitro. Actin remodelling was followed by stain-
ing of filamentous actin (F-actin) and globular actin (G-actin), the two
main forms actin is present in cells (Figure 5A, left). The n-3PUFA treat-
ment caused a reduction in the number of polarized CD4þ T cells, i.e.
cells with a leading edge (pseudopod), in the presence of the pro-
migratory stimulus CXCL10 (Figure 5A, top right). Although a similar
trend was observed in the absence of CXCL10, the number of sponta-
neously polarized cells was low, and the results did not reach statistical
significance (Supplementary material online, Figure S4A). Furthermore,
the F-actin/G-actin ratio—a measure of how dynamic the cytoskeleton
is—was also reduced by both EPA and DHA, consistent with the ob-
served reduced polarization (Figure 5A, bottom right). The monounsatu-
rated fatty acid oleic acid did not show the same effect as EPA or DHA
on cell morphology (Supplementary material online, Figure S5), confirm-
ing the specificity of n-3PUFA.
Further mechanistic insight was sought by analysing the expression of
the small Rho GTPase, Rhoa and Rac1, two key orchestrators of cell po-
larization and migration.44,45 Treatment of activated CD4þ T cells with
EPA and/or DHA in the presence or absence of CXCL10, caused a re-
duction of Rhoa and Rac1 total protein levels as well as of the active,
GTP-bound form, which is responsible of the regulation of the cytoskel-
etal dynamics (Figure 5B and C and Supplementary material online, Figure
S4B).
To assess the potential functional consequences of the observed n-
3PUFA-induced Rhoa and Rac1 down-regulation, we analysed the phos-
phorylation levels of the downstream target of Rhoa and Rac1, MLC2
and PAK1/2, respectively,46–48 and found that they were both decreased
(Figure 5B and C). Finally, staining Rhoa and F-actin in EPA- and DHA-
treated CD4þ T cells, with or without CXCL10, showed distinct pat-
terns of localization of Rhoa: while most untreated control cells were
polarized with Rhoa mainly found at the pseudopods (Figure 5D), the
majority of EPA- and DHA-treated cells had a round shape with Rhoa
showing an even distribution along the cell membrane or in the cyto-
plasm (Figure 5D).
3.5 n-3PUFA affect the distribution of
glycerophospholipids and SMs in CD4þ
T cell membrane microdomains
EPA and DHA can modify the lipid composition of the plasma mem-
brane and this can affect the formation and structure of the membrane
microdomains important for delivering signals that modify the cytoskele-
tal dynamics.49–52 The impact of n-3PUFA on the lipid composition of
CD4þ T cell membrane microdomains was explored through profiling
of membrane lipids by UHPSFC/ESI-QTOF-MSE. For this, we analysed
the relative abundance and distribution of glycerophospholipids, sphin-
golipids, and acylglycerides in DRM fractions prepared from CD4þ
T cells treated ex vivo with EPA, DHA (20lM), or vehicle (control) using
a sucrose gradient (Figure 6 and Supplementary material online, Figures
S6–S8). The low density DRM separated in Fr. 1–3 roughly represent
‘lipid rafts’.37
In control untreated T cells, the predominant SM species were SM
34:1, SM 36:1, SM 38:4, SM 42:2, and SM 46:7 (Figure 6A). Profiling individ-
ual SM species across the 10 gradient fractions showed an enrichment of
SM 34:1 and SM 42:2 in the DRM (Fr. 1–3) and SM 36:1, SM 38:4, and SM
46:7 in the high density detergent soluble membrane (DSM) fractions
(Fr. 8–10) (Supplementary material online, Figure S6A). The most abun-
dant glycerophosphatidylcholine (PC) species were PC 33:1, PC 34:1,
and PC 36:2. While saturated, monounsaturated and polyunsaturated
PC species were enriched in the DRM (Fr. 1–3) and intermediate density
(Fr. 4–7) fractions, PC species containing more than two double bonds
were found enriched in the intermediate density fractions (Fr. 4–7)
(Figure 6A and D and Supplementary material online, Figures S6B and S7).
Glycerophosphatidylethanolamines (PE) were less abundant than SM
and PS. The main PE species identified were PE 30:1, PE 34:4p/34:5e, PE
38:3, PE 46:6, and PE 46:1; although these were found distributed across
all density fractions, monounsaturated PE species were found enriched
in DSM fractions (Fr. 8–10) (Figure 6A and D and Supplementary material
online, Figure S6C). Finally, triacylglycerides were found mostly in either
the DRM (Fr. 1–3) or DSM (Fr. 8–10) fractions (Supplementary material
online, Figure S6E), whereas diacylglycerides were found mostly accumu-
lated in the intermediate density fractions (Fr. 4–7) (Supplementary ma-
terial online, Figure S6F).
Treatment with DHA altered the lipid composition of the membrane
microdomains, across the sucrose gradient fractions (Figure 6A–D and
Supplementary material online, Figures S6A–F, S7, and S8). Although the
distribution of total phospholipids and acylglycerides did not change, the
relative abundance of lipid species was altered. In detail: DHA caused an
enrichment of monounsaturated SM, PC, and PE species in the DRM
fractions and reduced polyunsaturated PC species in the intermediate
density fractions (Fr. 4–7) (P< 0.05) and monounsaturated PE species in
the DSM fractions (Fr. 8–10) (P< 0.05), all compared to untreated con-
trols (Figure 6D and Supplementary material online, Figure S8).
Conversely, EPA was less effective that DHA and had no effect on the
re-distribution of SM and PC species, although it appeared to shift mono-
unsaturated PE species to the DRM (Figure 6A and Supplementary mate-
rial online, Figure S6C). The observed changes suggest that DHA is more
12 D. Cucchi et al.
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..efficient than EPA in modifying DRM membrane structures, with poten-
tial implications for the fluidity of the cellular membrane and impact
upon related signalling pathways.
3.6 Lipid microdomain disruption exerts
the same effect as EPA and DHA
treatment
The impact of EPA and DHA on membrane microdomains may also dis-
rupt the signalling pathways to Rho GTPase proteins downstream of
chemokine signalling.52 To test this hypothesis, CXCL10-stimulated
CD4þ T cells were treated in vitro with the cyclodextrin MbCD, a high
molecular weight cyclic oligosaccharide able to deplete cholesterol from
biological membranes, thus impeding lipid microdomain formation.53
This resulted in a reduction in cell polarization and F-actin/G-actin ratio,
similar to that observed following T cell treatment with EPA and DHA
(Figure 7A). The expression of the small Rho GTPase, Rhoa, and Rac1
was also reduced (Figure 7C) while the cellular distribution of Rhoa was
altered in a way similar to the EPA and DHA treatments, showing an
even distribution around the plasma membrane as compared to the
pseudopod accumulation in the CXCL10-treated cells (Figure 7B).
4. Discussion
The importance of adaptive immunity in the establishment of a chronic,
low-grade inflammation in CVMD is now becoming clear and new inter-
ventions are needed to combat this unwanted inflammatory response
and re-establish physiological tissue homeostasis. The anti-inflammatory
protective effects of n-3PUFA extend to the cardiovascular and immune
systems, and here we examined their impact on the properties and tissue
distribution of CD4þ T cells, crucial orchestrators of inflammatory
responses in cardiometabolic disease.
The n-3PUFA supplementation modified the balance among the T cell
populations reducing the pro-inflammatory T cells in most of the fat tis-
sues examined; this was accompanied by a concomitant increase in the
central memory CD44hiCD62Lhi CD4þ T cells (Figure 1). Our findings
support the anti-inflammatory profile of n-3PUFA suggesting that their
activities are mediated, at least in part, through changes in T cell proper-
ties including motility. Although not assessed here, n-3PUFA supplemen-
tation is considered beneficial in other organs including the liver where it
has been shown to confer protection against damage in the setting of
steatosis and high-fat diet by reducing ceramide production and regulat-
ing sphingolipid biosynthesis.54,55
N-3PUFA can modify the network of bioactive lipid mediators, both
locally and systemically, altering the prevalence of chemotactic lipid spe-
cies with consequence for the migratory capacity of T cells.21 Profiling
the mediator lipidome in the target lymphoid and fat tissues, and plasma,
showed reduction of AA-derived mediators, together with increased
production of EPA- and DHA-derived species, and reduction of ceram-
ides (Figure 2). While AA mediators are considered pro-inflammatory,
their EPA and DHA counterparts appear to be either less potent or pre-
sent anti-inflammatory protective profiles, and reduced levels of ceram-
ides have been linked to improvement in cardiovascular disease.20,21,26
Changes in the composition of the tissue lipid milieu may have affected
the distribution pattern of locally detected CD4þ T cells, therefore se-
lected bioactive lipid species were assessed for their potency as chemo-
attractants as well as for their ability to interfere with the effect of
CXCL10, a potent inflammatory chemokine. In the absence of any other
migratory stimulus, 19,20-DiHDPA, AEA and N(16)S(18)C1P increased
the migration of CD4þ T cells in vitro (Figure 3A). The endocannabinoid
AEA and C1P N(16)S(18)C1P were found reduced by the n-3PUFA
treatment in perigonadal and subcutaneous fat, and this may have led to
the decrease in CD44þ T cells found in fat tissues (Figure 1). 19,20-
DiHDPA, a product of DHA, was increased post-supplementation in all
tissues examined, and its ability to act as chemoattractant may have also
contributed to the CD4þ T cells subtype profiles observed in lymphoid
and fat tissues. 18-HEPE, a product of EPA and precursor of pro-
resolving mediators was also increased post-supplementation.56
However, unlike 19,20-DiHDPA, AEA and N(16)S(18)C1P, 18-HEPE
did not have any effect on the migratory response of activated CD4þ
T cells. Although other studies have shown the activity of EPA- and DHA-
derived pro-resolving lipids (e.g. RvE and RvD), these were not identified
in the tissues analysed, suggesting that, if formed, their levels were below
the level of detection of the assays used in our experimental settings.56,57
Our findings (Figure 1) are the result of multiple changes in the net-
work of lipid mediators, all occurring as a result of the n-3PUFA diet, and
the exact contribution and properties of individual species should be fur-
ther explored. When assessed in the presence of CXCL10, the octade-
canoid 9-HOTrE and eicosanoid PGE2 were able to counteract the
potent effect of this chemokine (Figure 3B). While 9-HOTrE was found
increased post n-3PUFA, the levels of PGE2 were reduced (Figure 2A),
showing the differential contribution of various lipid mediators in the
anti-inflammatory effect of n-3PUFA diets. It is therefore evident that the
metabolism of n-3PUFA and subsequent perturbation of bioactive lipids
have diverse effects on the migratory ability of T cells, but the overall bal-
ance is towards an anti-inflammatory protective effect suggesting that di-
etary supplementation may regulate the function of T cells.
Further to their metabolism to bioactive mediators, EPA and DHA
may also be directly involved in the regulation of T cell migration. As
shown (Figure 4), both fatty acids can down-regulate the migratory capa-
bility of activated CD4þ T cells, ex vivo and, more importantly, in vivo, in a
peritoneal recruitment assay, suggesting that some of their anti-
inflammatory effects may be attributed to inhibition of immune cell mi-
gration. Interestingly, at least in vitro, EPA and DHA do not interfere with
the differentiation of CD4þ T cell subsets, or with their proliferation and
survival. Therefore, the different T cell subsets found in adipose and lym-
phoid tissues of n-3PUFA fed mice could be due to the effect of fatty
acids on trafficking rather than differentiation.
EPA and DHA could also act at cellular level altering the ability of
T cells to respond to migratory stimuli. Analysis of the polarization of
activated and CXCL10-stimulated CD4þ T cells showed that treatment
with EPA or DHA reduced formation of pseudopods and decrease the
ratio between F-actin and G-actin, a measurement of cellular dynamic-
ity.45 Moreover, this change happened in concomitance with the down-
regulation of Rhoa and Rac1, two small Rho GTPases involved in cell mi-
gration (Figure 5). These findings show that EPA and DHA can interfere
with the molecular machinery necessary for migration to occur, and
although the exact signals triggered are not yet known, our results
demonstrate that n-3PUFA have a direct impact on cytoskeletal
rearrangements.
The observation that EPA and DHA down-regulate the expression
rather than activity of Rhoa and Rac1 (Figure 5B and C) suggest that they
trigger signals able to interfere with Rhoa and Rac1 transcriptional or
post-translational regulation; elucidation of these molecular signals and
their control mechanisms requires further investigation. However, the
consequent decrease in phosphorylation of two downstream targets,
Omega-3 fatty acids impact CD4þ T cell trafficking and adipose tissue distribution 13
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respectively, pMLC2 and pPAK1/2, indicates that the down-regulation of
Rhoa and Rac1 is functional. Furthermore, treatment with EPA or DHA
changed the cellular localization of Rhoa, from the pseudopods pro-
duced upon stimulation with CXCL10, to a cytoplasmic localization.
These events suggest a broader interference with membrane-related
events.
To explore this further, we assessed the impact of n-3PUFA on cel-
lular membrane composition with emphasis on the DRM microdo-
mains, important for receptor clustering and cell signalling relevant to
cell motility.49–52 EPA and DHA treatment of CD4þ T cells ex vivo,
showed a re-distribution of phospholipid species with DHA being
more efficient than EPA in increasing the relative abundance of mono-
unsaturated SM, PC, and PE species in DRM fractions, whereas EPA
only shifted monounsaturated PE species to DRMs (Figure 6). This ob-
servation agrees with biophysical studies suggesting that not all n-
3PUFA are equivalent in altering membrane organization.58 DRM
crudely represent the ‘lipid raft’ microdomains that appear necessary
for the correct assembly of the molecular machinery required for cell
migration. However, our data shows that DHA and EPA had similar
effects on the T cell motility parameters studied, therefore we can
conclude that the changes in T cell ‘lipid raft’ composition were not
sufficient to differentially alter the underlying mechanisms responsible
for the physiological effects we have observed.
Overall, our results demonstrate that n-3PUFA exert their anti-
inflammatory properties by acting in multiple ways: at a systemic level
they modify the network of lipid mediators in fat and lymphoid tissues,
thus causing the redistribution of the different CD4þ T cell subsets in fa-
vour of an anti-inflammatory phenotype (dampening the pro-
inflammatory immune response); at a cellular level, they can affect the cy-
toskeletal rearrangements required for the migration of activated CD4þ
T cells. Whether n-3PUFA influence the T cell response via alteration of
the processes of antigen presentation remains to be further investigated.
Recent findings suggest that n-3PUFA have a strong influence on
the properties of B lymphocytes, macrophage subsets, and dendritic
cells;59–61 exploring the impact of systemic and cellular changes in these
cells would greatly improve our understanding of the immunomodula-
tory activities and potential benefit of n-3PUFA supplementation.
Nevertheless, the findings of this study add to the current debate of
whether EPA and DHA can improve cardiovascular outcomes, and offer
support to the use of n-3PUFA in addressing the low-grade inflammatory
reactions accompanying cardiometabolic disease, while their molecular
mechanism of action offers targets for the development of novel thera-
peutics and/or interventions.
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Translational perspective
The n-3PUFA EPA and DHA, found in fish oils, have been explored as means of preventing cardiovascular disease and improving cardiometabolic risk
factors. Although the efficiency of n-3PUFA is debated, recent clinical studies have shown that EPA supplementation can reduce the risk of ischemic
events and increase the stability of the atherosclerotic plaque, with EPA plaque levels inversely related to their T cell content. While the immunomod-
ulatory properties of n-3PUFA are appreciated, the underpinning molecular mechanisms are not fully understood. Our data add to our understanding
of the immunomodulatory properties of n-3PUFA and their beneficial effects.
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